A new infusion of capital is set to accelerate NVision Quantum Technologies' work in advanced medical imaging. The company, which engineers quantum-powered MRI technologies for deeper, more precise data, has raised $38.0M in a Series B round.
Investors EIB and Abbott backed the funding, which supports NVision's unique hyperpolarization device, POLARIS. This technology enables fast, simple, scalable imaging of metabolism at the cellular level, promising earlier detection and faster treatment assessment across oncology, cardiology, and neurology.















